Pain Management Therapeutics Market is Expected to Cross US$ 83 Billion by 2024


No comments posted yet


Slide 1

Pain Management Therapeutics Market is Expected to Cross US$ 83 Billion by 2024 Market Research Engine has published a new report titled as “Pain Management Therapeutics Market by Therapeutics Analysis (Antidepressants, Anesthetics, Anticonvulsants, Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic); by Indication Analysis (Migraine, Cancer Pain, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Post- operative Pain) - Global Industry Analysis and Forecast 2016 - 2024”. The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period. Browse Full Report: management-therapeutics-market Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year. The major driving factors of pain management therapeutics market are as follows: Approving health care reforms and regulatory scenario Increasing approval of pain management therapeutics between end users Increasing in geriatric population with high risk of different diseases Growing frequency of chronic pain disorders The restraining factors of pain management therapeutics market are as follows: Enduring pain relief from medical devices, alternative therapies and surgical procedures Prescription drug exploitation Exclusive rights expiry of entry of generics and key drugs The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market

Slide 2

covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: An overview of the global market for pain management therapeutics and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024. Identifications of new market opportunities and targeted promotional plans for pain management therapeutics. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in the industry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Pain management therapeutics Market has been segmented as below: By Therapeutics Analysis Antimigraine agents Non steroidal anti inflammatory drugs Anesthetics Antidepressants Anticonvulsants Opioids Tramadol Hydrocodones Oxycodaones Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)

Slide 3

Other non narcotic analgesic By Indication Analysis Cancer pain Post operative pain Migraine Arthritic pain Chronic back pain Fibromyalgia Neuropathic pain By Regional Analysis North America Europe Asia-Pacific Rest of the World Sample Report: therapeutics-market Table of Contents 1. INTRODUCTION 2 Research Methodology Global Pain Management Therapeutics Market – Industry Analysis North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024 Country Snippet Company Profiles Abbott Laboratories AstraZeneca Depomed, Inc.

Slide 4

Endo Pharmaceuticals, Inc. GlaxoSmithKline plc Johnson & Johnson Mallinckrodt Pharmaceuticals Merck & Co., Inc. Novartis AG Pfizer, Inc. Purdue Pharma L.P. Teva Pharmaceutical Industries Limited Reasons to Buy this Report: Obtain the most up to date information available on all pain management therapeutics market globally. Identify growth segments and opportunities in the industry. Facilitate decision making on the basis of strong historic and forecast of pain management therapeutics data. Assess your competitor’s refining portfolio and its evolution. About Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. Media Contact Company Name: Market Research Engine Contact Person: John Bay Email: Phone: +1-855-984-1862 Country: United States

Slide 5


Summary: The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.

Tags: pain management therapeutics market